Plan Selection in Medicare Part D: Evidence from Administrative Data
47 Pages Posted: 16 Jun 2012 Last revised: 20 Feb 2022
Date Written: June 2012
Abstract
We study the Medicare Part D prescription drug insurance program as a bellwether for designs of private, non-mandatory health insurance markets, focusing on the ability of consumers to evaluate and optimize their choices of plans. Our analysis of administrative data on medical claims in Medicare Part D suggests that less than 10 percent of individuals enroll in plans that are ex post optimal with respect to total cost (premiums and co-payments). Relative to the benchmark of a static decision rule, similar to the Plan Finder provided by the Medicare administration, that conditions next year's plan choice only on the drugs consumed in the current year, enrollees lost on average about $300 per year. These numbers are hard to reconcile with decision costs alone; it appears that unless a sizeable fraction of consumers value plan features other than cost, they are not optimizing effectively.
Suggested Citation: Suggested Citation
Do you have negative results from your research you’d like to share?
Recommended Papers
-
Adverse Selection in Insurance Markets: Policyholder Evidence from the U.K. Annuity Market
By Amy Finkelstein and James M. Poterba
-
Estimating Risk Preferences from Deductible Choice
By Alma Cohen and Liran Einav
-
Estimating Risk Preferences from Deductible Choice
By Alma Cohen and Liran Einav
-
The Role of Commitment in Dynamic Contracts: Evidence from Life Insurance
By Igal Hendel and Alessandro Lizzeri
-
Asymmetric Information and Learning: Evidence from the Automobile Insurance Market
By Alma Cohen
-
Private Information and its Effect on Market Equilibrium: New Evidence from Long-Term Care Insurance
-
The Interaction of Public and Private Insurance: Medicaid and the Long-Term Care Insurance Market
By Jeffrey R. Brown and Amy Finkelstein
-
The Interaction of Public and Private Insurance: Medicaid and the Long-Term Care Insurance Market
By Jeffrey R. Brown and Amy Finkelstein
-
Sources of Advantageous Selection: Evidence from the Medigap Insurance Market
By Hanming Fang, Michael P. Keane, ...
-
Sources of Advantageous Selection: Evidence from the Medigap Insurance Market
By Hanming Fang, Michael P. Keane, ...